-
1 Comment
Global Bioenergies SA is currently in a long term downtrend where the price is trading 3.5% below its 200 day moving average.
From a valuation standpoint, the stock is 1056.0% more expensive than other stocks from the Utilities sector with a price to sales ratio of 1007.3.
Global Bioenergies SA's total revenue sank by 0.0% to $2M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 289.6% to $5M since the same quarter in the previous year.
Based on the above factors, Global Bioenergies SA gets an overall score of 1/5.
CurrencyCode | EUR |
---|---|
ISIN | FR0011052257 |
Sector | Utilities |
Exchange | PA |
Industry | Utilities-Diversified |
Beta | 1.97 |
---|---|
Dividend Yield | 0.0% |
Target Price | 5 |
PE Ratio | None |
Market Cap | 33M |
Global Bioenergies SA engages in the development of a process for converting plant-based feedstocks into isobutene used in the cosmetic and aviation fuel industry. The company also offers engineering services in gas fermentation process. In addition, it develops a process to convert gaseous carbon sources, such as CO2, CO, and industrial emissions comprising syngas into various chemical compounds. The company was incorporated in 2008 and is headquartered in Evry, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALGBE.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024